Results 11 to 20 of about 1,081,205 (298)

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

open access: yesJournal of the American Medical Association (JAMA), 2020
Importance In December 2019, novel coronavirus (2019-nCoV)-infected pneumonia (NCIP) occurred in Wuhan, China. The number of cases has increased rapidly but information on the clinical characteristics of affected patients is limited.
Dawei Wang   +13 more
semanticscholar   +1 more source

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.

open access: yesJAMA Neurology, 2020
Importance The outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, is serious and has the potential to become an epidemic worldwide. Several studies have described typical clinical manifestations including fever, cough, diarrhea, and fatigue.
L. Mao   +12 more
semanticscholar   +1 more source

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.

open access: yesJournal of the American Medical Association (JAMA), 2020
Importance There is limited information describing the presenting characteristics and outcomes of US patients requiring hospitalization for coronavirus disease 2019 (COVID-19). Objective To describe the clinical characteristics and outcomes of patients
S. Richardson   +26 more
semanticscholar   +1 more source

Symptoms and risk factors for long COVID in non-hospitalized adults

open access: yesNature Medicine, 2022
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is associated with a range of persistent symptoms impacting everyday functioning, known as post-COVID-19 condition or long COVID.
A. Subramanian   +36 more
semanticscholar   +1 more source

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

open access: yesNew England Journal of Medicine, 2020
Background No therapeutics have yet been proven effective for the treatment of severe illness caused by SARS-CoV-2. Methods We conducted a randomized, controlled, open-label trial involving hospitalized adult patients with confirmed SARS-CoV-2 infection,
B. Cao   +64 more
semanticscholar   +1 more source

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.

open access: yesJAMA cardiology, 2020
Importance Coronavirus disease 2019 (COVID-19) has resulted in considerable morbidity and mortality worldwide since December 2019. However, information on cardiac injury in patients affected by COVID-19 is limited.
Shao-bo Shi   +12 more
semanticscholar   +1 more source

Theorizing hospitality [PDF]

open access: yesHospitality & Society, 2011
This new journal has been motivated by a paradox. As each of us has explored questions of hospitality from within our different areas of research, we have been struck by the extent to which the field has become intrinsically inhospitable to the interdisciplinary study of hospitality.
Lynch, Paul   +4 more
openaire   +2 more sources

Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report

open access: yesmedRxiv, 2020
Background: Coronavirus disease 2019 (COVID-19) is associated with diffuse lung damage. Corticosteroids may modulate immune-mediated lung injury and reducing progression to respiratory failure and death.
P. Horby   +25 more
semanticscholar   +1 more source

Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020

open access: yesMMWR. Morbidity and mortality weekly report, 2020
Since SARS-CoV-2, the novel coronavirus that causes coronavirus disease 2019 (COVID-19), was first detected in December 2019 (1), approximately 1.3 million cases have been reported worldwide (2), including approximately 330,000 in the United States (3 ...
S. Garg   +37 more
semanticscholar   +1 more source

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

open access: yesNew England Journal of Medicine, 2020
Background Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progression to respiratory failure and death.
P. Horby   +25 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy